Forbes

New research suggests deep-sea vent metals powered early metabolism before enzymes existed, revealing how life may have begun making essential molecules on Earth.

A new era in tuberculosis care has begun with the introduction of a highly affordable molecular test, priced at just $2.60. Global rollout is now underway.

EHR giant Epic Systems is hinting it may use AI tools to directly empower patients with their health data, rather than just giving providers tools to do so if they wish.

Ambient scribing technology can significantly improve operational efficiency and physician workloads.

A public health expert explains the rise of cannabis use disorder, what it is, and what it means for public health

A new study shows cancer genes are not destiny: genetic background can shape whether inherited cancer risk becomes disease, when it begins, and how it develops.

For four generations, Rome’s Angelini family has built a $2.5 billion operation with drugs for depression and epilepsy in Europe. Now it’s bought its way into the U.S. market.

In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.

Full body MRIs may detect early, symptomless cancer tumors or other serious issues, but may also return benign findings that cause unecessary anxiety and intervention.